- Vitamins and Supplements 2014
- ROUNDTABLE: Pharmacy’s future in sync with technology
- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- Consumer trust intact as McNeil brands like Tylenol return back to shelf
FORT WASHINGTON, Pa. McNeil Consumer Healthcare once again is recalling certain lots of its products as it is probed by federal investigators for its recall of children’s cough-cold products and manufacturing plant closure.
The J&J subsidiary announced Wednesday morning that four lots of Benadryl allergy ultratab tablets (100 count) and one lot of Extra Strength Tylenol rapid-release gels (50 count) would be added to its initial Jan. 15 product recall. This recall, McNeil said, is a follow-up to the product recall because the products were inadvertently omitted from the initial recall action.
Benadryl allergy ultratab tablets are designed to provide relief of such allergy-associated symptoms as sneezing, runny nose, itchy throat and itchy and watery eyes. Extra strength Tylenol rapid-release gels are sold over-the-counter and are indicated for the temporary reduction of fever, as well as for the temporary relief of minor aches and pains due to headache, muscular aches, backache, minor arthritis pain, the common cold, toothache, premenstrual and menstrual cramps, and flu.
Consumers who purchased product from the lots included in this recall should stop using the product and contact McNeil Consumer Healthcare for instructions on a refund or replacement, the company said.
The Committee on Oversight and Government Reform is continuing its probe of the J&J subsidiary.